These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 42526)

  • 21. Retention of graft-vs-host activity in non-adherent spleen cells after depletion of cytotoxic activity by incubation on allogeneic target cells.
    Mage MG; McHugh LL
    J Immunol; 1973 Aug; 111(2):652-5. PubMed ID: 4146231
    [No Abstract]   [Full Text] [Related]  

  • 22. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulation by low-dose methotrexate. I. Methotrexate selectively inhibits Lyt-2+ cells in murine acute graft-versus-host reactions.
    Gibbons JJ; Lucas J
    J Immunol; 1989 Mar; 142(6):1867-73. PubMed ID: 2784139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplification of the graft-versus-host reaction by cyclophosphamide: dependence on timing of drug administration.
    Lehnert S; Rybka WB
    Bone Marrow Transplant; 1994 Apr; 13(4):473-7. PubMed ID: 8019473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Increase of the GvH reaction after alloimmunization. Influence of the serologically defined determinants of the H-2 system].
    Brock J; Siegl E; Schulze HA
    Allerg Immunol (Leipz); 1982; 28(2):91-6. PubMed ID: 6182783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on graft versus host (GvH) reactions. I. Impairment of hemopoietic stroma in mice suffering from GvH disease.
    Hirabayashi N
    Exp Hematol; 1981 Feb; 9(2):101-10. PubMed ID: 7238646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of graft versus host reactivity in pregnant mice.
    Nicklin S; Billington WD
    Clin Exp Immunol; 1982 Jul; 49(1):135-41. PubMed ID: 7127896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the role of macrophages in the graft-versus-host reaction.
    Sůla K; Nouza K
    Folia Biol (Praha); 1985; 31(1):38-49. PubMed ID: 2982674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
    Hakim FT; Shearer GM
    J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo allogeneic effects: shift in the isotype profile of primary TI-2 responses in mice undergoing graft-vs-host reaction.
    Golding H; Rittenberg MB
    J Immunol; 1982 Nov; 129(5):1878-82. PubMed ID: 6749981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific suppression of the local GVH reaction by F1 spleen cells.
    Tagashira Y
    Acta Med Okayama; 1982 Aug; 36(4):253-61. PubMed ID: 6215832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of proline-rich polypeptide on donor cells in graft-versus-host reaction.
    Zimecki M; Janusz M; Starościk K; Lisowski J; Wieczorek Z
    Immunology; 1982 Sep; 47(1):141-7. PubMed ID: 6981586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Suppression of the graft vs host reaction after the inoculation of lymphocytes into the liver of F1 hybrid mice].
    Divanian Kh; Stoianov S; Softova E
    Eksp Med Morfol; 1983; 22(3):30-3. PubMed ID: 6671447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.